US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist
  • 1.930
  • +0.060+3.21%
Close Aug 30 16:00 ET
  • 1.900
  • -0.030-1.55%
Post 20:01 ET
28.53MMarket Cap-2294P/E (TTM)

MIRA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
78.38%1.73M
32.01%1.77M
20.97%8.53M
126.78%3.06M
74.75%3.16M
-59.92%970.22K
-8.96%1.34M
227.48%7.05M
1.35M
1.81M
Selling and administrative expenses
4.20%1.12M
63.77%1.01M
117.22%6.5M
5,067.33%2.67M
191.39%2.14M
-32.65%1.07M
-0.49%614.24K
288.53%2.99M
--51.66K
--736.06K
-General and administrative expense
4.20%1.12M
63.77%1.01M
117.22%6.5M
5,067.33%2.67M
191.39%2.14M
-32.65%1.07M
-0.49%614.24K
288.53%2.99M
--51.66K
--736.06K
Research and development costs
708.26%614.46K
180.66%762.28K
-33.11%1.57M
-56.25%387.12K
42.00%1.02M
-137.50%-101.02K
-43.30%271.61K
243.56%2.35M
--884.76K
--714.97K
Other operating expenses
----
----
-73.39%453.55K
--0
----
----
20.98%453.55K
144.32%1.7M
--411.3K
--357.35K
Operating profit
-78.38%-1.73M
-32.01%-1.77M
-20.97%-8.53M
-126.78%-3.06M
-74.75%-3.16M
59.92%-970.22K
8.96%-1.34M
-227.48%-7.05M
-1.35M
-1.81M
Net non-operating interest income expense
113.31%39.4K
3,149.97%50.42K
-33,619.94%-3.46M
-154,544.45%-2.73M
-18,440.62%-427.73K
-12,681.30%-295.89K
57.20%-1.65K
57.95%-10.25K
-1.77K
-2.31K
Non-operating interest income
--39.4K
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
----
33,619.94%3.46M
154,544.45%2.73M
18,440.62%427.73K
12,681.30%295.89K
----
-57.95%10.25K
--1.77K
--2.31K
Total other finance cost
----
-3,149.97%-50.42K
----
----
----
----
--1.65K
----
----
----
Other net income (expense)
Income before tax
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
-1.81M
Income tax
Net income
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
-1.81M
Net income continuous Operations
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
---1.35M
---1.81M
Minority interest income
Net income attributable to the parent company
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
-1.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
-1.81M
Basic earnings per share
-28.11%-0.11
-20.00%-0.12
-60.95%-0.64
-415.03%-0.3915
-154.88%-0.26
37.09%-0.0859
0.04%-0.1
-169.38%-0.3976
-0.076
-0.102
Diluted earnings per share
-28.11%-0.11
-20.00%-0.12
-60.95%-0.64
-415.03%-0.3915
-154.88%-0.26
37.09%-0.0859
0.04%-0.1
-169.38%-0.3976
-0.076
-0.102
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 78.38%1.73M32.01%1.77M20.97%8.53M126.78%3.06M74.75%3.16M-59.92%970.22K-8.96%1.34M227.48%7.05M1.35M1.81M
Selling and administrative expenses 4.20%1.12M63.77%1.01M117.22%6.5M5,067.33%2.67M191.39%2.14M-32.65%1.07M-0.49%614.24K288.53%2.99M--51.66K--736.06K
-General and administrative expense 4.20%1.12M63.77%1.01M117.22%6.5M5,067.33%2.67M191.39%2.14M-32.65%1.07M-0.49%614.24K288.53%2.99M--51.66K--736.06K
Research and development costs 708.26%614.46K180.66%762.28K-33.11%1.57M-56.25%387.12K42.00%1.02M-137.50%-101.02K-43.30%271.61K243.56%2.35M--884.76K--714.97K
Other operating expenses ---------73.39%453.55K--0--------20.98%453.55K144.32%1.7M--411.3K--357.35K
Operating profit -78.38%-1.73M-32.01%-1.77M-20.97%-8.53M-126.78%-3.06M-74.75%-3.16M59.92%-970.22K8.96%-1.34M-227.48%-7.05M-1.35M-1.81M
Net non-operating interest income expense 113.31%39.4K3,149.97%50.42K-33,619.94%-3.46M-154,544.45%-2.73M-18,440.62%-427.73K-12,681.30%-295.89K57.20%-1.65K57.95%-10.25K-1.77K-2.31K
Non-operating interest income --39.4K------------------------------------
Non-operating interest expense --------33,619.94%3.46M154,544.45%2.73M18,440.62%427.73K12,681.30%295.89K-----57.95%10.25K--1.77K--2.31K
Total other finance cost -----3,149.97%-50.42K------------------1.65K------------
Other net income (expense)
Income before tax -33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M-1.81M
Income tax
Net income -33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M-1.81M
Net income continuous Operations -33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M---1.35M---1.81M
Minority interest income
Net income attributable to the parent company -33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M-1.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M-1.81M
Basic earnings per share -28.11%-0.11-20.00%-0.12-60.95%-0.64-415.03%-0.3915-154.88%-0.2637.09%-0.08590.04%-0.1-169.38%-0.3976-0.076-0.102
Diluted earnings per share -28.11%-0.11-20.00%-0.12-60.95%-0.64-415.03%-0.3915-154.88%-0.2637.09%-0.08590.04%-0.1-169.38%-0.3976-0.076-0.102
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg